Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study.

dc.contributor.author	Aomar Millán, I.
dc.contributor.author	Salvatierra, Juan
dc.contributor.author	Torres Parejo, Úrsula
dc.contributor.author	Faro-Miguez, Naya
dc.contributor.author	Callejas Rubio, José Luis
dc.contributor.author	Ceballos Torres, Ángel
dc.contributor.author	Cruces Moreno, María Teresa
dc.contributor.author	Gómez Jiménez, Francisco Javier
dc.contributor.author	Hernández Quero, José
dc.contributor.author	Anguita-Santos, F.
dc.date.accessioned	2025-01-28T11:25:53Z
dc.date.available	2025-01-28T11:25:53Z
dc.date.issued	2021-06
dc.identifier.citation	Aomar-Millán IF, Salvatierra J, Torres-Parejo Ú, Faro-Miguez N, Callejas-Rubio JL, Ceballos-Torres Á, Cruces-Moreno MT, Gómez-Jiménez FJ, Hernández-Quero J, Anguita-Santos F. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study. Intern Emerg Med. 2021 Jun;16(4):843-852. doi: 10.1007/s11739-020-02600-z. (IF: 3.4; Q2)	es_ES
dc.identifier.uri	https://hdl.handle.net/10481/100739
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 Internacional	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.title	Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study.	es_ES
dc.type	journal article	es_ES
dc.rights.accessRights	open access	es_ES
dc.identifier.doi	10.1007/s11739-020-02600-z

Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional